Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
Labeling: Label Mix-Up
Subpotent Drug
CGMP Deviations
Butter lists cream, but may be missing the Contains Milk statement.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.
CGMP violations.
Patulin. Apple Cider was found to have elevated levels of patulin after receiving analytical testing results from 3rd party laboratory. Lab sample detected 78 ppb; limit is 50 ppb.
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.